• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Clinical Trial Registry Accuracy and Maintenance in ALS/MND Research
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition, Swallowing and Saliva
      • Activities of Daily Living and Occupational Therapy
      • Muscles, Mobility and Exercise
      • Respiratory Care
      • Speech and Communication
      • Voice Preservation
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
    • R.A.C.E. to Diagnose ALS/MND
  • Programs & Events
    • Calendar of Events
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
  • Members
    • Member Registration
    • Forgot Password

Admin

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Forum Topics Started

Viewing 2 topics - 1 through 2 (of 2 total)
    • Topic
    • Voices
    • Posts
    • Last Post
    • Coronavirus (COVID-19)

      Started by: Admin in: Member Forum

    • 0
    • 1
    • 6 years, 6 months ago

      Admin

    • Forum Guidelines

      Started by: Admin in: Member Forum

    • 1
    • 1
    • 10 years, 1 month ago

      Admin

  •  

Viewing 2 topics - 1 through 2 (of 2 total)

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition, Swallowing and Saliva
  • Activities of Daily Living and Occupational Therapy
  • Muscles, Mobility and Exercise
  • Respiratory Care
  • Speech and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Programs & Events

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Meetings
  • Awards

Upcoming Events

Oct 13
8:00 am - 9:00 am EDT

Member Forum: Technology Solutions for PALS

Oct 13
6:00 pm - 7:00 pm EDT

Member Forum: Technology Solutions for PALS

Oct 15
9:00 am - 10:00 am EDT

Webinar: The Use of AI in ALS/MND

Oct 17
2:00 pm - 3:00 pm EDT

ALS Association Webinar: So, What’s Next? Understanding the Decisions along an ALS Journey

Oct 21
7:00 am - 8:30 am EDT

Member Roundtable: Defining Rights in the Genetics Era of ALS/MND

View Calendar

  • Willi Klein, UK

    Willi Klein, UK

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Andrew Langat, Kenya

    Andrew Langat, Kenya

  • Jack Buzby, USA

    Jack Buzby, USA

  • Bjarne Hytjanstorp, Norway

    Bjarne Hytjanstorp, Norway

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Carlos Alberto Arango, Colombia

    Carlos Alberto Arango, Colombia

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Alejandro Aquino, Argentina

    Alejandro Aquino, Argentina

  • David Watson, Scotland

    David Watson, Scotland

  • Ian Gale, Australia

    Ian Gale, Australia

  • Fabrice Kamp, Germany

    Fabrice Kamp, Germany

  • Brigitte Wernli, Switzerland

    Brigitte Wernli, Switzerland

  • Armando González Gómez, Colombia

    Armando González Gómez, Colombia

  • Malcolm Buck, Australia

    Malcolm Buck, Australia

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Dick Dayton, USA

    Dick Dayton, USA

  • Murat Morali, Turkey

    Murat Morali, Turkey

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Duncan Bayly, Australia

    Duncan Bayly, Australia

  • Valdomiro Xavier Honório, Brazil

    Valdomiro Xavier Honório, Brazil

  • Christian Bär, Germany

    Christian Bär, Germany

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Guido De Mets, Belgium

    Guido De Mets, Belgium

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Peng Yi-Wen, Taiwan

    Peng Yi-Wen, Taiwan

  • Sally Pauls, USA

    Sally Pauls, USA

  • Timothy Holman, Switzerland

    Timothy Holman, Switzerland

  • Len Johnrose, England

    Len Johnrose, England

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Jette Odgaard Villemoes, Denmark

    Jette Odgaard Villemoes, Denmark

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login